Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 46, 2020 - Issue 1
Submit an article Journal homepage
293
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial

Elias Dakwara Division on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USACorrespondence[email protected]
View further author information
,
Amy Mahonya Division on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USAView further author information
,
C. Jean Choib New York State Psychiatric Institute, Biostatistics, New York, USAView further author information
,
Martina Pavlicovac Mailman School of Public Health, Biostatistics, Columbia University, New York, NY, USAView further author information
,
Daniel Brooksa Division on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USAView further author information
,
John J. Mariania Division on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USAView further author information
&
Frances R. Levina Division on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USAView further author information
 show all
Pages 44-48 | Received 06 Aug 2017, Accepted 13 May 2019, Published online: 24 Jul 2019

References

  • World Health Organization. Cannabis. Geneva, Switzerland: WHO; 2015.
  • Marshall K, Gowing L, Ali R, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2014;12:10.
  • McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat. 2003;24:369–76.
  • Gish EC, Miller JL, Honey BL, Johnson PN. Lofexidine, an α2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010;44:343–51. doi:10.1345/aph.1M347.
  • Kelly MA, Pavlicova M, Glass A, Mariani JJ, Bisaga A, Sullivan MA, Nunes EV, Levin FR. Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug Alcohol Depend. 2014 Nov 1;144:42–46. doi:10.1016/j.drugalcdep.2014.06.040.
  • Ramos BP, Arnsten AF. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther. 2007;113:523–36. doi:10.1016/j.pharmthera.2006.11.006.
  • Sallee FR. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder. Postgrad Med. 2010;122:78–87. doi:10.3810/pgm.2010.09.2204.
  • Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A, Morgan PT, Sinha R. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings. J Psychopharmacol. 2012;26:958–72. doi:10.1177/0269881111430746.
  • Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Herman BH. A phase 3 placebo-controlled, double blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. Drug Alcohol Depend. 2008;97:158–68. doi:10.1016/j.drugalcdep.2008.04.002.
  • Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Foltin RW. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 2008;197:157–68. doi:10.1007/s00213-007-1020-8.
  • Sagvolden T. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). Behav Brain Funct. 2006;2:41. doi:10.1186/1744-9081-2-41.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Dunbar GC. The Mini-International Neuropsychiatric Interview (MINI): development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.
  • Mariani JJ, Brooks D, Haney M, Levin FR. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend. 2011;113:249–51. doi:10.1016/j.drugalcdep.2010.08.008.
  • Heishman SJ, Singleton EG, Liguori A. Marijuana craving questionnaire: development and initial validation of a self-report instrument. Addiction. 2001;96:1023–34. doi:10.1080/09652140120053084.
  • Markowitz JS, Rabkin JG, Stewart J, Tricamo E, McGrath PJ, Harrison W, Ocepek-Welikson K, Quitkin FM. Validity assessment of SAFTEE: a preliminary report. Psychopharmacol Bull. 1987;23:102–05.
  • Levin FR, McDowell D, Evans SM, Nunes E, Akerele E. Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict. 2004;13:21–32. doi:10.1080/10550490490265280.
  • Buchan BJ, L Dennis M, Tims FM, Diamond GS. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction. 2002;97:98–108.
  • Marshall K, Gowing L, Ali R, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2014;12:CD008940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.